Correlation of DNA methylation of DNMT3A and TET2 with oral squamous cell carcinoma

被引：5
作者：
Li, Xueming [1 ,2 ]
Li, Zaikun [1 ]
Gao, Qingxi [1 ]
Peng, Yanan [1 ]
Yu, Yang [1 ]
Hu, Tenglong [1 ]
Wang, Wei [1 ]
机构：
[1] Harbin Med Univ, Dept Oral & Maxillofacial Surg, Affiliated Hosp 1, Harbin 150001, Peoples R China
[2] Harbin Med Univ, Key Lab Hepatosplen Surg, Minist Educ, Affiliated Hosp 1, Harbin, Peoples R China
来源：
DISCOVER ONCOLOGY | 2024年 / 15卷 / 01期
关键词：
EXPRESSION; METHYLTRANSFERASES; EPIGENETICS; 3A;
D O I：
10.1007/s12672-024-00866-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Oral squamous cell carcinoma (OSCC) is the sixth most common malignancy worldwide. Abnormal epigenetic modifications, including DNA methylation, are hallmarks of cancer and implicated in the development of various tumors. DNA methylation is catalyzed by the DNA methyltransferase and ten-eleven translocation dioxygenase families, with DNMT3A and TET2 being the most widely studied members, respectively. The correlation of methylation beta values and clinical features was conducted in patients with OSCC in The Cancer Genome Atlas database. DNA methylation and protein expression levels of DNMT3A and TET2 in tissues were analyzed with methylation-specific polymerase chain reaction (MSP) and western blotting. To evaluate the effects of DNMT3A and TET2 on the biological characteristics of OSCC, cell proliferation was assessed with 5-ethynyl-2'-deoxyuridine, and cell migration capacity was quantified with wound healing and transwell assays. A survival analysis was performed with the Kaplan-Meier approach. The correlation between different methylation beta values and clinical features was revealed. MSP revealed varying methylation degrees of DNMT3A and TET2 in OSCC tissues. Furthermore, western blotting showed that the protein expression levels were significantly different in cancer and surrounding healthy tissue samples. In vitro experiments demonstrated that DNMT3A knockdown and TET2 overexpression could inhibit the proliferation and migration of OSCC. Survival analysis revealed that patients with high DNMT3A methylation levels showed higher survival rates.
引用
收藏
页数：13
相关论文
共 50 条
[41]   Natural Compounds: DNA Methyltransferase Inhibitors in Oral Squamous Cell Carcinoma [J].
Jha, Meenakshi ;
Aggarwal, Ruchi ;
Jha, Abhimanyu Kumar ;
Shrivastava, Anju .
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2015, 177 (03) :577-594
[42]   A review of the alterations in DNA methylation in esophageal squamous cell carcinoma [J].
Baba, Yoshifumi ;
Watanabe, Masayuki ;
Baba, Hideo .
SURGERY TODAY, 2013, 43 (12) :1355-1364
[43]   Myelodysplastic Syndrome associated TET2 mutations affect NK cell function and genome methylation [J].
Boy, Maxime ;
Bisio, Valeria ;
Zhao, Lin-Pierre ;
Guidez, Fabien ;
Schell, Berenice ;
Lereclus, Emilie ;
Henry, Guylaine ;
Villemonteix, Juliette ;
Rodrigues-Lima, Fernando ;
Gagne, Katia ;
Retiere, Christelle ;
Larcher, Lise ;
Kim, Rathana ;
Clappier, Emmanuelle ;
Sebert, Marie ;
Mekinian, Arsene ;
Fain, Olivier ;
Caignard, Anne ;
Espeli, Marion ;
Balabanian, Karl ;
Toubert, Antoine ;
Fenaux, Pierre ;
Ades, Lionel ;
Dulphy, Nicolas .
NATURE COMMUNICATIONS, 2023, 14 (01)
[44]   Reduced ribosomal RNA expression and unchanged ribosomal DNA promoter methylation in oral squamous cell carcinoma [J].
Ha, Shanshan ;
Zhou, Hong ;
Gautam, Mayank ;
Song, Yaling ;
Wang, Changning .
MOLECULAR GENETICS & GENOMIC MEDICINE, 2019, 7 (07)
[45]   DNA methylation in oral squamous cell carcinoma: from its role in carcinogenesis to potential inhibitor drugs [J].
Flausino, Carolina Simao ;
Daniel, Filipe Ivan ;
Modolo, Filipe .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 164
[46]   Association of polymorphisms in DNMT1, DNMT3A, DNMT3B, MTHFR and MTRR genes with global DNA methylation levels and prognosis of autoimmune thyroid disease [J].
Arakawa, Y. ;
Watanabe, M. ;
Inoue, N. ;
Sarumaru, M. ;
Hidaka, Y. ;
Iwatani, Y. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2012, 170 (02) :194-201
[47]   Sohlh2 Inhibits the Malignant Progression of Renal Cell Carcinoma by Upregulating Klotho via DNMT3a [J].
Liu, Yang ;
Cui, Weiwei ;
Zhang, Ruihong ;
Zhi, Sujuan ;
Liu, Lanlan ;
Liu, Xuyue ;
Feng, Xiaoning ;
Chen, Yanru ;
Zhang, Xiaoli ;
Hao, Jing .
FRONTIERS IN ONCOLOGY, 2022, 11
[48]   DNA hypermethylation driven by DNMT1 and DNMT3A favors tumor immune escape contributing to the aggressiveness of adrenocortical carcinoma [J].
Kerdivel, Gwenneg ;
Amrouche, Floriane ;
Calmejane, Marie-Ange ;
Carallis, Floriane ;
Hamroune, Juliette ;
Hantel, Constanze ;
Bertherat, Jerome ;
Assie, Guillaume ;
Boeva, Valentina .
CLINICAL EPIGENETICS, 2023, 15 (01)
[49]   Influence of TGFBR2, TGFB3, DNMT1, and DNMT3A Knockdowns on CTGF, TGFBR2, and DNMT3A in Neonatal and Adult Human Dermal Fibroblasts Cell Lines [J].
Tomela, Katarzyna ;
Karolak, Justyna ;
Ginter-Matuszewska, Barbara ;
Kabza, Michal ;
Gajecka, Marzena .
CURRENT ISSUES IN MOLECULAR BIOLOGY, 2021, 43 (01) :276-285
[50]   DNA Methylation Markers from Negative Surgical Margins Can Predict Recurrence of Oral Squamous Cell Carcinoma [J].
Sorroche, Bruna Pereira ;
Talukdar, Fazlur Rahman ;
Soares Lima, Sheila Coelho ;
Melendez, Matias Eliseo ;
de Carvalho, Ana Carolina ;
de Almeida, Gisele Caravina ;
De Marchi, Pedro ;
Lopes, Monique ;
Ribeiro Pinto, Luis Felipe ;
Carvalho, Andre Lopes ;
Herceg, Zdenko ;
Rebolho Batista Arantes, Lidia Maria .
CANCERS, 2021, 13 (12)
12345